![Raul Rodriguez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raul Rodriguez
Directeur Général chez
RIGEL PHARMACEUTICALS, INC.
Fortune : 11 M $ au 30/06/2026
Profil
Raul R.
Rodriguez is currently President, Chief Executive Officer & Director at Rigel Pharmaceuticals, Inc. since 2014, with employment at the company starting in 2000.
Formerly, Mr. Rodriguez was Executive Director-Business Development at Scios, Inc. from 1994 to 1997 and Senior VP-Business Development & Operations at Ontogeny, Inc. from 1997 to 2000.
Education includes graduate studies at the University of Illinois, an MBA from Stanford Graduate School of Business, and undergraduate studies at Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/06/2026 | 279 593 ( 1,51 % ) | 11 M $ | 30/06/2026 |
Postes actifs de Raul Rodriguez
| Sociétés | Poste | Début |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Directeur Général | 21/11/2014 |
Anciens postes connus de Raul Rodriguez
| Sociétés | Poste | Fin |
|---|---|---|
Ontogeny, Inc.
 Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | Directeur des opérations | 01/03/2000 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Corporate Officer/Principal | 01/03/1997 |
Formation de Raul Rodriguez
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | Health Technology |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
